VERA vs. BRK-B
Compare and contrast key facts about Vera Therapeutics, Inc. (VERA) and Berkshire Hathaway Inc. (BRK-B).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VERA or BRK-B.
Correlation
The correlation between VERA and BRK-B is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VERA vs. BRK-B - Performance Comparison
Key characteristics
VERA:
-0.59
BRK-B:
1.25
VERA:
-0.62
BRK-B:
1.85
VERA:
0.93
BRK-B:
1.23
VERA:
-0.79
BRK-B:
2.23
VERA:
-1.77
BRK-B:
5.25
VERA:
20.15%
BRK-B:
3.56%
VERA:
59.97%
BRK-B:
14.93%
VERA:
-84.89%
BRK-B:
-53.86%
VERA:
-40.48%
BRK-B:
-0.41%
Fundamentals
VERA:
$1.87B
BRK-B:
$1.04T
VERA:
-$2.61
BRK-B:
$49.44
VERA:
$0.00
BRK-B:
$276.52B
VERA:
$952.00K
BRK-B:
$48.42B
VERA:
-$103.90M
BRK-B:
$98.94B
Returns By Period
In the year-to-date period, VERA achieves a -29.98% return, which is significantly lower than BRK-B's 6.29% return.
VERA
-29.98%
-12.14%
-24.31%
-33.54%
N/A
N/A
BRK-B
6.29%
2.82%
7.30%
17.73%
16.06%
12.61%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VERA vs. BRK-B — Risk-Adjusted Performance Rank
VERA
BRK-B
VERA vs. BRK-B - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vera Therapeutics, Inc. (VERA) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VERA vs. BRK-B - Dividend Comparison
Neither VERA nor BRK-B has paid dividends to shareholders.
Drawdowns
VERA vs. BRK-B - Drawdown Comparison
The maximum VERA drawdown since its inception was -84.89%, which is greater than BRK-B's maximum drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for VERA and BRK-B. For additional features, visit the drawdowns tool.
Volatility
VERA vs. BRK-B - Volatility Comparison
Vera Therapeutics, Inc. (VERA) has a higher volatility of 25.61% compared to Berkshire Hathaway Inc. (BRK-B) at 4.62%. This indicates that VERA's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
VERA vs. BRK-B - Financials Comparison
This section allows you to compare key financial metrics between Vera Therapeutics, Inc. and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities